Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Chemo and Zevalin in Relapsed Follicular Lymphoma
NCT00637832Phase 2Terminated
- Sponsor
- University of Southampton
- Start
- Apr 2008
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in follicular lymphoma (FL), sponsored by University of Southampton. Started Apr 2008; status: terminated.
02
Drugs
ibritumomab tiuxetan
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00637832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637832.